BRTX
BioRestorative Therapies, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.69
+1.32%Next report
Analyst consensus
- Next report date
- Sep 22, 2026
- EPS estimate
- -$2.00
- Revenue estimate
- $600.0K
Latest reported
- Last report date
- May 14, 2026
- EPS actual
- -$0.19
- EPS estimate
- -$0.30
- Revenue actual
- $23.2K
- Revenue estimate
- $312.5K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +15.9%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 14, 2026 | -$0.30 | -$0.19 | Beat 36.67% | $23.2K |
| Mar 26, 2026 | -$0.37 | -$0.37 | In line | $19.6K |
| Nov 12, 2025 | -$0.38 | -$0.38 | In line | $11.8K |
| Aug 12, 2025 | -$0.41 | -$0.30 | Beat 26.83% | $303.3K |
| May 14, 2025 | -$0.32 | -$0.56 | Miss -75.00% | $25.0K |
| Mar 27, 2025 | -$0.27 | -$0.20 | Beat 25.93% | $43.3K |
| Jun 11, 2024 | -$0.51 | -$0.53 | Miss -3.92% | $35.0K |
| Mar 29, 2024 | -$0.65 | -$0.57 | Beat 12.31% | $19.3K |
| Aug 11, 2023 | -$1.56 | -$0.77 | Beat 50.64% | $64.5K |
| May 12, 2023 | -$1.26 | -$1.53 | Miss -21.43% | $31.3K |
| Mar 24, 2023 | -$1.43 | -$1.18 | Beat 17.48% | $3.7K |
| Nov 14, 2022 | -$0.49 | -$1.28 | Miss -161.22% | $29.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026